Oppenheimer & Company Trimmed Its Dicks Sporting Goods (DKS) Position; Last Week Acadia Healthcare Company, Inc. (ACHC) Analysts

February 17, 2018 - By Winifred Garcia

Oppenheimer & Company Inc decreased Dicks Sporting Goods Inc (DKS) stake by 20.48% reported in 2017Q3 SEC filing. Oppenheimer & Company Inc sold 40,228 shares as Dicks Sporting Goods Inc (DKS)’s stock declined 18.06%. The Oppenheimer & Company Inc holds 156,243 shares with $4.22 million value, down from 196,471 last quarter. Dicks Sporting Goods Inc now has $3.60B valuation. The stock decreased 0.09% or $0.03 during the last trading session, reaching $33.54. About 2.68 million shares traded. Dick's Sporting Goods, Inc. (NYSE:DKS) has declined 1.35% since February 17, 2017 and is downtrending. It has underperformed by 18.05% the S&P500.

Among 17 analysts covering Acadia Healthcare (NASDAQ:ACHC), 11 have Buy rating, 0 Sell and 6 Hold. Therefore 65% are positive. Acadia Healthcare had 48 analyst reports since August 6, 2015 according to SRatingsIntel. Craig Hallum maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) rating on Thursday, October 26. Craig Hallum has “Buy” rating and $41.0 target. On Wednesday, October 25 the stock rating was downgraded by Deutsche Bank to “Hold”. Leerink Swann initiated Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Tuesday, September 1 with “Outperform” rating. The company was maintained on Thursday, August 6 by Mizuho. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has “Hold” rating given on Wednesday, October 25 by Robert W. Baird. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, July 5. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) earned “Buy” rating by RBC Capital Markets on Friday, September 1. The firm has “Buy” rating by Jefferies given on Tuesday, September 5. Citigroup initiated the stock with “Buy” rating in Wednesday, January 4 report. As per Wednesday, October 25, the company rating was maintained by Citigroup. See Acadia Healthcare Company, Inc. (NASDAQ:ACHC) latest ratings:




30/01/2018 Broker: Wells Fargo Rating: Buy New Target: $41.0
09/01/2018 Broker: Cantor Fitzgerald Rating: Hold New Target: $39.0 Maintain
13/12/2017 Broker: Robert W. Baird Rating: Hold New Target: $37.0 Maintain
03/11/2017 Broker: Credit Suisse Rating: Hold New Target: $35.0 Initiate
30/10/2017 Broker: Mizuho Old Rating: Buy New Rating: Neutral Downgrade
26/10/2017 Broker: Craig Hallum Rating: Buy New Target: $41.0 Maintain
26/10/2017 Broker: BMO Capital Markets Rating: Outperform Old Target: $52 New Target: $48 Maintain
25/10/2017 Broker: Citigroup Rating: Buy Old Target: $61 New Target: $44 Maintain
25/10/2017 Broker: Cantor Fitzgerald Rating: Neutral Old Target: $48 New Target: $39 Maintain
25/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $38.0 Downgrade

Oppenheimer & Company Inc increased Everest Re Group Ltd (NYSE:RE) stake by 2,000 shares to 10,335 valued at $2.36 million in 2017Q3. It also upped Broadcom Ltd stake by 1,876 shares and now owns 34,541 shares. Johnson Ctls Intl Plc was raised too.

Among 36 analysts covering Dick’s Sporting Goods Inc. (NYSE:DKS), 16 have Buy rating, 2 Sell and 18 Hold. Therefore 44% are positive. Dick’s Sporting Goods Inc. had 141 analyst reports since July 27, 2015 according to SRatingsIntel. Credit Suisse maintained the stock with “Neutral” rating in Wednesday, November 15 report. Monness Crespi & Hardt maintained the shares of DKS in report on Wednesday, March 9 with “Buy” rating. The firm has “Hold” rating given on Wednesday, August 16 by Goldman Sachs. The rating was upgraded by Wolfe Research to “Outperform” on Tuesday, March 14. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, July 20. The rating was maintained by Argus Research on Tuesday, August 30 with “Buy”. The rating was upgraded by Citigroup on Tuesday, December 19 to “Buy”. UBS maintained the stock with “Buy” rating in Wednesday, November 18 report. The company was maintained on Thursday, December 14 by Morgan Stanley. BMO Capital Markets maintained the shares of DKS in report on Wednesday, November 15 with “Buy” rating.

Analysts await Dick's Sporting Goods, Inc. (NYSE:DKS) to report earnings on March, 6. They expect $1.17 earnings per share, down 11.36% or $0.15 from last year’s $1.32 per share. DKS’s profit will be $125.65M for 7.17 P/E if the $1.17 EPS becomes a reality. After $0.30 actual earnings per share reported by Dick's Sporting Goods, Inc. for the previous quarter, Wall Street now forecasts 290.00% EPS growth.

Investors sentiment decreased to 0.8 in 2017 Q3. Its down 0.01, from 0.81 in 2017Q2. It dropped, as 83 investors sold DKS shares while 103 reduced holdings. 47 funds opened positions while 102 raised stakes. 75.65 million shares or 8.17% less from 82.39 million shares in 2017Q2 were reported. 159,916 are held by Citigroup. Bamco Incorporated Ny reported 1.05 million shares stake. Wisconsin-based Northwestern Mutual Wealth Mgmt Com has invested 0% in Dick's Sporting Goods, Inc. (NYSE:DKS). Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 0% of its portfolio in Dick's Sporting Goods, Inc. (NYSE:DKS) for 12,349 shares. Cs Mckee Lp reported 515,075 shares. Menta Limited Liability invested in 25,803 shares or 0.1% of the stock. Prudential Financial Inc holds 0.05% of its portfolio in Dick's Sporting Goods, Inc. (NYSE:DKS) for 1.16 million shares. Arcadia Invest Mi has invested 0.08% in Dick's Sporting Goods, Inc. (NYSE:DKS). 298 were reported by Lenox Wealth Mngmt Inc. 73,087 are owned by Quantbot Techs Ltd Partnership. 13 are held by Country Tru National Bank. Artemis Investment Management Llp reported 0.17% in Dick's Sporting Goods, Inc. (NYSE:DKS). Nomura Incorporated reported 13,341 shares. Manning Napier Advsr Lc stated it has 0.28% in Dick's Sporting Goods, Inc. (NYSE:DKS). First Trust Advsrs Limited Partnership reported 0.01% of its portfolio in Dick's Sporting Goods, Inc. (NYSE:DKS).

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company has market cap of $3.19 billion. The companyÂ’s acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It has a 18.37 P/E ratio. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

The stock increased 0.14% or $0.05 during the last trading session, reaching $36.32. About 2.09M shares traded or 62.49% up from the average. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 23.20% since February 17, 2017 and is downtrending. It has underperformed by 39.90% the S&P500.

Since August 22, 2017, it had 0 insider purchases, and 7 selling transactions for $146.25 million activity. Shares for $25.35 million were sold by JACOBS JOEY A on Tuesday, August 22. WAUD REEVE B sold $3.18 million worth of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) on Friday, December 15. Shares for $2.72M were sold by Howard Christopher L on Tuesday, August 22. 80,000 shares were sold by Fincher Ronald Morgan, worth $4.06 million on Tuesday, August 22. Another trade for 206,252 shares valued at $10.45M was sold by TURNER BRENT. $50.61 million worth of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was sold by Gordon Christopher R.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.